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SPECIAL FOCUS: DRIED BLOOD SPOTS
SPECIAL REPORT
Clinical and/or toxicological analyses are gener-
ally performed using blood/plasma obtained by 
venipuncture. In 1963, whole blood collected on 
filter paper was successfully introduced for the 
neonatal screening of phenylketonuria [1]. Briefly, 
the technique consists of peripheral blood col-
lection by heel or fingerprick and blotting onto 
specially manufactured, high-quality filter paper. 
The blood spot is then air dried and stored in 
low gas permeable bags that contain desiccant 
to reduce humidity, at ambient temperature or 
frozen at -20 °C. Before ana lysis, a disc of dried 
blood spots (DBS) typically 3.0 or 6.0 mm in 
diameter, equivalent to 3.1 or 12.4 µl of whole 
blood, respectively, is punched either manually 
or by automated machine. In 1997, Rashed devel-
oped in-house a high-throughput automated 
method and a software program to read DBS 
sample IDs by barcode, and to map them into 
the 96-well microplate positions; amino acid and 
acylcarnitine profiles from DBS were obtained in 
less than 2 min per sample [2]. Today, fully auto-
mated equipment is commercially available that 
is able to identify by barcode, punch and insert 
the DBS samples into a 96-well microplate, cre-
ating an accurate record of the location of each 
sample [101,102]. Over the years, specific methods 
have been developed for the ana lysis of several 
compounds from DBS for chemical, serological 
and genetic applications, but primarily for the 
expanded newborn screening of inborn errors 
of metabolism (IEM) [3].
The DBS sample collection technique shows 
significant advantages over conventional blood 
collection (longer lifespan of samples with 
reduced need for refrigeration, less invasive, more 
cost effective, easy shipment and storage, and 
reduction of infection risks by deactivation of 
potential pathogens on the filter paper [4–6,103]). 
DBS has also achieved the same level of preci-
sion and reproducibility as standard methods 
that collect blood in vacuum tubes and capillary 
pipettes [4]; so DBS is simple to perform and can 
be collected in a variety of environments. It also 
has the advantage that it can be archived on a 
long-term basis and used in retrospective diagno-
sis. Thus, it can elucidate previously unexplain-
able cases of sudden infant death, for example, or 
can be used to indicate the true incidence value 
of many underestimated diseases.
Due to these advantages, DBS use in clinical 
and research settings has expanded to include 
testing for many diseases [7] and monitoring 
of therapeutic agents including antimalarials, 
antiepileptics, antiretrovirals, antidiabetics and 
antibiotics [8–13]. In principle, any compound 
measurable in whole blood, serum or plasma 
can also be measured in DBS. The dried blood 
matrix stabilizes many labile molecules, includ-
ing DNA, thereby allowing measurement of 
both phenotype (biochemical marker) and 
genotype (mutation or polymorphism) from 
a small volume of blood [4,14]. DBS is also a 
potentially valid method for the screening 
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of cardiometabolic risk factors in developing 
countries [15] and for the screening of certain 
inherited diseases that require the measurement 
of enzyme activities [16,17]. Obviously, the mol-
ecules of interest must remain stable when dried 
and must be released from the paper during the 
ana lysis. Many studies on the stability and mea-
surability of compounds in the dried matrix have 
been performed [18–26].
An important analytical aspect linked to DBS 
procedure is that the limited sample volume may 
be problematic in terms of sensitivity required 
for assay development and validation. It should 
also be systematically assessed for the potential 
impact of various blood-sample properties on the 
accurate quantification of the analyte of interest. 
The limited sample volume is compensated for 
by the use of highly sensitive mass spectrom-
eters (MS) or tandem MS (MS/MS), coupled 
to liquid chromatography (LC) as a separating 
method, and by use of the isotope-dilution tech-
nique for the accurate quantification of meta-
bolic pro!les (e.g., acylcarnitines and amino 
acids) [19,27–29]. In fact, DBS–LC–MS/MS has 
emerged as an important method for quantita-
tive ana lysis of a myriad of small molecules [29]. 
Another disadvantage of the DBS procedure is 
the offline solvent extraction step. Recently, an 
online DBS sample procedure has been proposed 
that allows direct extraction and ana lysis, using 
a conventional column switching LC–MS sys-
tem, to be integrated into a single process [30,31]. 
However, all procedures described above are 
time consuming owing to sample preparation 
and chromatography steps. 
In the past 2 years, a number of direct elution 
approaches have been published in the literature. 
Abu-Rabie and Spooner reported a TLC–MS 
interface as a potential and effective tool for 
the direct ana lysis of drugs in DBS samples at 
physiologically relevant concentrations, with or 
without HPLC separation [32]. This bioanalytical 
procedure was considered to be more time  and 
cost effective, as well as much simpler, when com-
pared with current manual practices (punching 
of DBS and elution with solvent prior to HPLC–
MS ana lysis). Furthermore, they showed an 
increased sensitivity compared with that of man-
ual extraction, potentially enabling the ana lysis of 
analytes not currently amenable to DBS sampling 
due to limitations in assay sensitivity. Van Berkel 
and Kertesz described the application of a liquid-
extraction-based sealing-surface-sampling probe 
(SSSP) for the direct mass spectrometric ana lysis 
of targeted drugs and metabolites in DBS [33]. 
More recently, the authors reported fully auto-
mated liquid extraction-based surface sampling 
and ionization using a chip-based robotic nano-
electrospray platform [34]. The system was tested 
with three types of sample surface: spotted sam-
ple arrays on a MALDI plate, DBS on paper, and 
whole-body thin tissue sections from drug-dosed 
mice. The results were consistent with previous 
studies employing other liquid-extraction-based 
surface sampling techniques. 
From these studies, it follows that the trend 
towards automation of the DBS procedure is 
making ana lysis faster and more reproducible. 
The next step consequently leads to the develop-
ment of new methods for the direct ana lysis of 
DBS, with the aim of obtaining results from a 
greater number of samples per minute.
Ambient ionization MS
The main limitation in using the mass spec-
trometer as a detector is the introduction of 
ionized sample compounds into the vacuum 
environment of the instrument. This problem 
was solved with the introduction of ‘soft’ atmo-
spheric pressure ionization (API) methods such 
as electrospray ionization (ESI), which is appli-
cable to large and fragile polar molecules, such 
as oligonucleotides and proteins [35,36], or atmo-
spheric pressure chemical ionization (APCI), a 
more versatile chemical ionization device used 
to analyze less polar small compounds [37] and 
the matrix-assisted laser desorption/ionization 
(MALDI) technique [38–40]. API techniques and 
the development of more versatile and sensitive 
mass spectrometers (MS and MS/MS), coupled 
with LC, dominate all analytical tools owing to 
their superior specificity, sensitivity, efficiency 
and efficacy, producing results at faster rates per 
sample. However, before performing LC–MS 
and LC–MS/MS ana lysis, it is necessary to per-
form a suitable sample preparation procedure 
(deproteinization, internal standard addition, 
centrifugation, extraction and derivatization). 
Thereafter, the chromatographic conditions 
must be optimized to provide the required sepa-
ration selectivity, the best ana lysis time and good 
compatibility with the MS detection [41,42]. 
Recently, some advanced API techniques have 
been introduced. In 2000, Laiko et al. intro-
duced a variant of the MALDI technique that 
allows ionization in an atmospheric environment 
(AP-MALDI) [43]. 
The next major ionization advance is based on 
the availability of MS sources that operate in the 
ambient environment, allowing the ionization 
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of ordinary/native samples, without sample 
preparation or preseparation, by creating ions 
outside the instrument [44]. The term a mbient 
MS (AMS) [45] is used to describe capabilities 
that are broader than those encompassed by the 
term atmospheric pressure MS [46]; it is an exten-
sion to MS that allows the ana lysis of samples at 
atmospheric pressure under ambient conditions. 
In AMS, samples are exposed to agents that cause 
desorption (or extraction) and ionization of com-
pounds present at or near the surface [47]. FIGURE 1 
shows a comparison between standard LC–MS 
and AMS procedure for a DBS sample. MS ana-
lysis without sample preparation could lead to the 
development of high-throughput ana lysis. AMS 
techniques have been used to perform ana lysis 
in different fields for biological [48–51], forensic 
[52,53] and pharmaceutical [54–56] applications. All 
of these are based on two fundamental principles 
described by Cooks et al. and by Cody et al., 
termed desorption ESI (DESI) and direct ana-
lysis in real-time (DART), respectively [44,45,57]. 
Prior to the DESI and DART methods, samples 
analyzed by MS were not in the free ambient 
environment and could not be subjected to arbi-
trarily chosen processing actions or conditions 
during the mass spectra acquisition [46].
Desorption ESI is an MS technique where 
charged droplets of solvent are directed onto a 
solid sample placed on a surface. The impact of 
the charged particles on the surface produces 
gaseous ions from material originally deposited 
on the surface. The resulting mass spectra are 
similar to those obtained by ESI, where the pro-
duced ions are mainly singly or multiply charged 
molecules [44–46]. In the DART process, neutral 
gas molecules, including metastable species, are 
produced by an electrical discharge in a gas phase 
that reacts with water and air molecules, resulting 
in a gas-phase chemical reaction that in combi-
nation with a desorption step, ionizes molecules 
directly from the surface. DESI, DART and 
other recently introduced AMS techniques, such 
as desorption APCI (DAPCI) [58], electrospray-
assisted laser desorption/ionization (ELDI) [59], 
and atmospheric solids analysis probe (ASAP) [60], 
can be considered atmospheric pressure versions 
of secondary ion MS (MS based on the collection 
and ana lysis of secondary ions emitted when a 
surface, solid or, sometimes, liquid, is bombarded 
by a focused primary ion beam). 
To date, many different AMS techniques 
have been proposed, of which the main ones are 
reported in TABLE 1. Readers interested in the 
Figure 1. Methods comparison for dried blood spots ana lysis by classical LC–MS and 
a mbient MS.
AMS: A mbient MS; DBS: Dried blood spots; IS: Internal standard.
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mechanisms of these techniques should refer 
to recent reviews elsewhere [61–63]. As is clear 
from the literature, compounds ranging from 
nonpolar small molecules, such as alkaloids and 
drugs, to polar compounds, such as peptides and 
proteins, can be analyzed selectively using DESI 
on solids, biological matrices and in vivo [45,64]. 
Instead, to analyze lipophilic compounds (such 
as cholesterol) that are not easily ionized by ESI 
and by DESI because of their lower proton affin-
ity, other AMS techniques have been developed, 
such as reactive DESI, which is used for the ana-
lysis of free cholesterol from human serum [65], 
and the ASAP to ionize sterols [66]. 
However, the quantitative performance of 
AMS techniques has not yet been sufficiently 
investigated. In fact, few works have demon-
strated that AMS could be used for quantita-
tive ana lysis. In 2008, Ifa et al. demonstrated 
that DESI-MS could be successfully employed 
for routine quantitative ana lysis by adding an 
internal standard [67], while in the same year 
Fernandez et al. used reactive DESI-MS to 
quantify active drugs (artesunate and antima-
larials) in solid pharmaceutical tablets using 
D4-artesunic acid as an internal standard [68]. 
In 2009, Manicke et al. described a new high-
throughput DESI source able to perform 
quantitative ana lysis of 96-sample arrays con-
taining pharmaceuticals in various matrices [69]. 
Finally, in 2010, Paglia et al. showed that the 
atmospheric pressure thermal desorption chemi-
cal ionization (APTDCI) technique, which 
easily ionizes sterols, can be used for quanti-
tative ana lysis of DBS from patients affected 
by the Smith–Lemli–Opitz syndrome [70], 
while Wiseman et al. described the quantita-
tive direct ana lysis of xenobiotics from DBS 
by DESI-MS without sample preparation or 
c hromatography [71].
Coupling of DBS & AMS for  
clinical biochemistry
Since the 1990s the application of DBS ana-
lysis by MS/MS to obtain metabolic profiles 
expanded the screening of IEM worldwide as a 
routine method [27]. Today, the fields of appli-
cation of DBS are varied and not exclusive to 
newborn screening or expanded newborn screen-
ing. Some more recent examples include the use 
of DBS in surveillance studies [72], for medical 
anthropological research [73], pharmacokinetic/
pharmacodynamic studies [74] and genetic stud-
ies [75]. As mentioned above, the utilization of 
DBS samples offers many advantages regarding 
collecting, processing, infectious hazard risk, 
Table 1. Main ambient ionization MS methods implemented in the last 6 years.
Mechanisms
Name Acronyms Desorption Ionization Ref.
Ambient solid analysis probe ASAP Thermal desorption (heated gas flow) Chemi- and chemical 
ionization
[60]
Atmospheric pressure thermal desorption  
chemical ionization 
APTDCI Thermal desorption (heated gas flow) Chemi- and chemical 
ionization
[76]
Atmospheric pressure-thermal desorption/
electrospray ionization 
AP-TD/ESI Thermal desorption (heated gas flow) ESI [79]
Desorption atmospheric pressure chemical 
ionization 
DAPCI Thermal desorption (charged droplets 
and heated gas flow)
Chemi- and chemical 
ionization
[80]
Desorption atmospheric pressure photoionization DAPPI Thermal desorption (charged droplets 
and heated gas flow)
Photoionization [81]
Desorption electrospray ionization  DESI Spray desorption (charged droplets) ESI [44]
Easy ambient sonic-spray ionization EASI Neutral spray desorption  
(neutral droplets)
ESI [82]
Direct analysis in real time DART Thermal desorption (heated gas flow) Chemi- and chemical 
ionization
[57]
Electrospray laser desorption/ionization ELDI Laser desorption ESI [59]
Laser-ablation electrospray ionization LAESI Laser desorption ESI [83]
Low temperature plasma LTP Electric discharge Chemi- and chemical 
ionization
[84]
Neutral desorption extractive  
electrospray ionization 
ND-EESI Ambient gas jet ESI [85]
Paper spray PS High voltage ESI [78]
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storage and transport. For these reasons, together 
with the development of new methodologies 
employing mass spectrometry and new ambi-
ent ionization, DBS ana lysis is becoming more 
prevalent in clinical and research laboratories. 
The next step is the in situ ana lysis of DBS by 
AMS. To date, three studies have demonstrated 
the direct ana lysis of DBS by AMS methods. 
Paglia and co-workers proposed the direct ana-
lysis of sterols from dried blood/plasma spots 
by APTDCI-MS/MS [70]. The method was 
first employed in 2008 for the ana lysis of acyl-
carnitines extracted from a pathological and 
control DBS samples [76]. Using this approach, 
the sterols were directly desorbed and ionized 
by APTDCI from DBS and quantified by MS 
using D6-cholesterol as a labeled internal stan-
dard. The implemented method was able to dif-
ferentiate normal subjects from Smith–Lemli–
Opitz syndrome patients [70]. The direct ana lysis 
of DBS by DESI-MS proposed by Wiseman 
et al. allows the quantitative determination of 
xenobiotics in whole blood samples without 
sample preparation or chromatography, which 
are usually used to minimize suppression effects 
on ionization and to preconcentrate the com-
pounds [71]. Using sitamaquine, terfenadine and 
prazosin as model compounds, with verapamil 
as an internal standard, this methodology could 
detect individual compound down to 10 ng/ml 
from DBS. The authors examined the effect of 
each surface on the recovery of each compound 
from various treated and untreated blood cards, 
showing that the untreated papers provide the 
best substrates for DBS ana lysis by DESI [71]. 
More recently, Wang et al. described a method, 
termed paper spray (PS), which combines the 
characteristics of both ESI and ambient ioniza-
tion methods. The method provides analyte 
transportation by applying a voltage to the wet 
paper, which is held in front of a mass spec-
trometer. PS was shown to be useful for fast, 
qualitative and quantitative ana lysis of complex 
mixtures. In particular, PS-MS and PS-MS/MS 
were used for the direct ana lysis of DBS from 
whole bovine blood enriched with the drug 
imatinib or atenolol, with labeled compounds 
added as internal standard to obtain a quanti-
tative ana lysis. The procedure was also applied 
to analyze illicit drugs from dried urine spots, 
which yielded PS-MS and PS-MS/MS spectra 
almost instantaneously [77,78].
While the gold standard approach to DBS 
ana lysis still requires the removal of a core from 
the DBS, compound(s) extraction and ana lysis 
by LC–MS/MS, the direct desorption/ionization 
approach, using DESI, APTDCI and PS, shows 
that the direct ana lysis of DBS samples is pos-
sible through the elimination of extensive sample 
preparation or cleanup. This could potentially 
lead to the development of high-throughput ana-
lysis; in fact, these results have wide implications 
for several applications including IEM, clinical 
analyses, therapeutic drug and substance abuse 
monitoring and clinical and forensic toxicol-
ogy. Furthermore, the use of specialty absorbent 
papers is not limited to whole blood; hence, the 
collection and ana lysis of plasma, urine and 
saliva as other volume-limited biological fluids 
on specialty papers are areas of further research, 
together with the development of papers for DBS 
that protect compounds in the dry state, and of 
papers more specific for DBS–AMS methods. 
Optimization of AMS methods and com-
parison with reference methods, improvement of 
quantitative ana lysis and validation of DBS–AMS 
methods, as well as automation of DBS–AMS 
methods, are the major points to be developed. 
Some automated devices for AMS ana lysis 
are already available [104–106], even though 
some automated steps (i.e., internal standard 
addition) for the direct ana lysis of DBS must 
still be developed, optimized and validated. In 
addition, the lack of conventional sample sepa-
ration (LC) could lead to possible issues with 
labile metabolites and often produce complex 
ion populations that can impact on the selective 
detection of isobaric species. As already reported, 
the DBS stabilizes many labile molecules, and 
AMS paired with an ion mobility/MS platform 
has shown the advantage of postsource (gas 
phase) electrophoretic analyte separation and 
should make a positive impact on AMS [55,63]. 
Finally, the lack of sample cleanup could lead to 
a dirty instrument, but more attention to clean-
ing the ion source entrance after each analyti-
cal session would be sufficient. Only when the 
sample concentration is above the higher limit 
of quantification would sample extraction and 
dilution be necessary.
Conclusion
The introduction of different AMS techniques 
to perform direct sampling/ionization and ana-
lysis of many compounds from raw samples 
provides the stimulating concept of direct 
MS ana lysis without sample pretreatment and 
separation. The ana lysis of DBS using AMS 
potentially offers several advantages, resulting 
in significant savings in time and cost, with no 
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requirement for the arduous sample handling 
procedures currently employed for conventional 
DBS ana lysis. Thus, this promising couple could 
represent a new mass spectrometric approach for 
the ana lysis of metabolic profiles directly in situ. 
Moreover, the combination of AMS with minia-
turized mass spectrometers could make it appli-
cable in nonlaboratory environments or usable 
by non-experts in MS (point-of-care devices) for 
clinical applications such as a bedside testing, or 
in vivo on the skin surface.
Future perspective
Dried blood spots can be qualitatively ana-
lyzed directly by AMS, in particular for small 
polar and nonpolar molecules. Many direct 
methods for the ana lysis of biomarkers will be 
implemented by DBS–AMS in several clinical 
fields such as diagnostic, epidemiology, phar-
macology, forensic and environmental sciences. 
These methods will form the basis for the in vivo 
a pplication of AMS in the near future. 
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Executive summary
Key conclusions
! Dried blood spots (DBS) as a sampling procedure have been in use for around 50 years, and specific paper/cards have been produced 
and tested by different analytical methods.
! The employment of DBS has followed the technological progress, and in the last 10 years DBS has been coupled to LC–MS/MS, while in 
the last 3 years DBS has been analyzed in situ using ambient MS (AMS; DBS–AMS).
! For accurate quantification of a compound, the DBS–AMS results must be compared with those of reference methods to validate this 
new procedure.
Unresolved issues
! Full automation of some pre-analytical steps such as addition of internal standard, handling of cards and verification of blood spots must 
still be developed. 
! Analytical variability of DBS is strictly linked to the chemical nature of compounds, and their stability in the paper depends on time and 
temperature of DBS storage, and distribution/chromatography of compounds in the paper during the collection and drying of blood.
! Accuracy and precision of DBS–AMS methods depend on internal standard addition, efficiency, efficacy and optimization of the 
desorption/ionization processes.
Point for emphasis for future work
! Papers for DBS that more specifically protect compounds in the dry state and that are more specific for DBS–AMS methods must  
be developed.
! Optimization of DBS–AMS methods and comparison with reference methods is needed.
! Improvement of quantitative ana lysis and validation of DBS–AMS methods.
! Development of new devices for the full automation of DBS–AMS methods.
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